References

• 1998Course of Tic Severity in Tourette Syndrome: The First Two Decades683 cited
• 2011European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment461 cited
• 2005Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's309 cited
• 2011The Neural Circuits That Generate Tics in Tourette's Syndrome304 cited
• 1991Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome273 cited
• 2002Elevated Intrasynaptic Dopamine Release in Tourette’s Syndrome Measured by PET259 cited
• 2007Mechanisms of Dopaminergic and Serotonergic Neurotransmission in Tourette Syndrome: Clues from an In Vivo Neurochemistry Study with PET253 cited
• 1996Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding252 cited
• 1982Stimulant Medications Precipitate Tourette's Syndrome247 cited
• 2012Systematic review: Pharmacological treatment of tic disorders – Efficacy of antipsychotic and alpha-2 adrenergic agonist agents238 cited
• 1995[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder223 cited
• 2012Canadian Guidelines for the Evidence-Based Treatment of Tic Disorders: Pharmacotherapy191 cited
• 2012Neuromodulation in Tourette syndrome: Dopamine and beyond